hemeonclinx Medical News about thyroid carcinomas; 14-3-3sigma expression

Oncology

Become a Member Today!

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Oncology

For Practicing
Oncologists

Conferences

Jobs

Newsletters

My Library

Topics in
Oncology

Alternative Therapies

Anemia/Polycythemia

BMT/SCT

Basic Science/Genetics

Bone/Cartilage

Breast

Carcinogenesis

Coagulation/Bleeding Dz

Colorectal Cancer/Polyps

Dermatologic Oncology

Diagnostics/Radiology

Economics of Medicine

Endocrine Oncology

GI Oncology

Gynecologic Oncology

Head and Neck

Hepatobiliary/Pancreas

Leukemia/Lymphoma

Lung/Thoracic Oncology

Myeloproliferative Dz

Neurologic Oncology

Pain/Palliative Care

Pediatric Heme/Oncology

Pharmacology/Therapy

Popular Press

Renal/Urologic

Side Effects

Soft Tissue/Sarcoma

Transfusion Medicine

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

For Practicing Oncologists

Providers Satisfied with Carriers/MACs
Roberta Buell, MBA, Sausalito Healthcare Partners

Cancer Science: Mutations in the ALK Receptor Kinase cause Neuroblastoma
Sara Hartley, MDLinx Oncology

Technology Advances: Laser Microscopy Offers Vista of Real-Time Cell Movements
Dorothy J. Schirf, MD, MDLinx Oncology

See all

thyroid carcinomas; 14-3-3sigma expression

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Regulation of 14-3-3sigma expression in human thyroid carcinoma is epigenetically regulated by aberrant cytosine methylation
Cancer Letters, 07/11/08

Print

Email This Article

Save in My Library

Free Abstract

Lal G et al. - 14-3-3sigma expression in thyroid carcinomas is regulated by CpG island hypermethylation.

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Screening for prostate cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine, 08/07/08

Antibiotic use predicts an increased risk of cancer
International Journal of Cancer, 08/20/08

Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 08/21/08

...All of Basic Science/Genetics

Sponsor

--- ENDOCRINE ONCOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 08/21/08

Vitamin D and sunlight: strategies for cancer prevention and other health benefits
Clinical Journal of the American Society of Nephrology, 09/05/08

Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer
Cancer, 09/18/08

...All of Endocrine Oncology

Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT

Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology

Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse

Medical Students
Nurse Practitioner
Pharma/Drug Marketer

Pharmacist
Physician
Physician Assistants

Article Search

Keyword:

Search:

Published within:

Sort By:
Date Relevance

Sponsor

Sponsor

| | | | | | |

English | Español | Français | Deutsch | 中文 | Руccкий | Norsk | Nederlands | Português | Italiano

©1999-2008 MDLinx, Inc.